Study of a Booster Dose of Hib-MenC Conjugate Vaccine vs Infanrix Hexa When Given to 14 Month Old Subjects

Clinical trial NCT00323050 · COMPLETED

Trial details

NCT number: NCT00323050
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neisseria Meningitidis Haemophilus Influenzae Type b

Start date: 2004-11-01
Primary completion: 2005-03-01
Enrollment: 468

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.